a. U.S. Patent 4,994,384 (Application 08/172,385 2, Specification, p. 4,11. 5-8;
p. 21,11. 14-15; p. 22,11. 19-21);
b. U.S. Patent 5,057,420 (Application 08/172,385, Specification, p. 4,11. 5-8);
C. Application 08/016,636 (Application 08/172,385, p. 5,11. 13-16);
d. Bondioli et al., "Bovine Nuclear Transplantation," International Application
No. PCT/US 88/01906, International Publication No. WO 88/09816,
December 15, 1988 (Application 08/172,385, Specification, p. 6,11. 1-15);
e. Bondioli et al., Theriogenology 33, 165-174, 1990 (Application 08/172,385,
Specification, p. 6,11. 1-15);
f. Bondolini et al., "Bovine Embryo In Vitro Culture," International Publication
No. WO 89/07135, (August 10, 1989) (Application 08/172,385,
Specification, p. 6,11. 1-15);
9- U.S. Patent 5,096,822 (Application 08/172,385, Specification, p. 6,11. 1-15;
p. 25,11. 22-23);
It. Strelchenko Application Attorney Docket No. 01-8416 (Application
08/169,830) filed December 17,1993 (Application 08/172,385, Specification,
p. 10, 11. 17-22; p. 17,11, 16-19);
i. Bondolini Application 07/915,779, filed July 11, 1992 (Application
08/172,385, Specification, p. 12,11.3-7);
j. Pursel et al., "Status of Research with Transgenic Farm Animal, " J. Animal
Sci., 71, 10-19, 1993 (Application 08/172,385, Specification, p. 12,11. 18
20); and
k. Application 08/016,703, filed February 10, 1993 (Application 08/172,385,
Specification, p. 23,11. 13-15).
The parties have submitted Ex. 1001 which is said to be a copy of the specification of Application
08/172,385. We do not enter it into evidence since it is not an accurate copy of the specification. Ex. 1001 appears to
be incomplete since it does not reflect all the amendments made to the written description during prosecution before
the examiner. Accordingly, we refer to the specification of Application 08/172,385 from PTO records.
-5-
Page: Previous 1 2 3 4 5 6 7 8 9 Next
Last modified: November 3, 2007